首页> 外文学位 >Communicating Data Visually: Data Presentation Formats at U.S. Food and Drug Administration Drug Advisory Committee Meetings.

【24h】

Communicating Data Visually: Data Presentation Formats at U.S. Food and Drug Administration Drug Advisory Committee Meetings.

机译：可视化通信数据：美国食品药品监督管理局药品咨询委员会会议上的数据表示格式。

获取原文

获取原文并翻译 | 示例

页面导航

摘要
著录项
相似文献
相关主题

摘要

This thesis investigated the use of tables and graphs to present quantitative data at U.S. FDA drug advisory committee meetings. A total of 7, 422 slides presented at such meetings in 2010 comprised the sample. All slides were coded for slide type; slides displaying graphs were also coded for graph type. Analyses were conducted to determine differences in data presentation format between the FDA and drug sponsors, slides shown to different types of advisory committees, and slides shown at meetings held for different purposes.;The study found that tables and graphs are used in almost equal measure at drug advisory committee meetings. However, the FDA is more likely than drug sponsors to display data in tables versus graphs. The study also found that the most prevalent graph formats are bar graphs, forest plots, line graphs, and Kaplan-Meier curves. Only one slide, shown by a drug sponsor, displayed a pictograph.

机译：本文研究了在美国FDA药物咨询委员会会议上使用表格和图表来呈现定量数据的方法。在2010年的此类会议上，共提供了7 422张幻灯片作为样本。所有幻灯片均已编码为幻灯片类型；显示图表的幻灯片也被编码为图表类型。进行了分析以确定FDA与药物赞助者之间数据呈现格式的差异，向不同类型的咨询委员会展示的幻灯片以及为不同目的而在会议上展示的幻灯片;该研究发现表格和图表的使用程度几乎相等在毒品咨询委员会会议上。但是，FDA比药物赞助商更有可能在表格或图表中显示数据。研究还发现，最流行的图形格式是条形图，森林图，折线图和Kaplan-Meier曲线。药品赞助商展示的只有一张幻灯片显示了象形文字。

著录项

作者
Smith, Lesley M.;
展开▼
作者单位

The University of North Carolina at Chapel Hill.;

展开▼
授予单位 The University of North Carolina at Chapel Hill.;
学科 Speech Communication.
学位 M.A.
年度 2011
页码 106 p.
总页数 106
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. [J] . Lurie P, Almeida CM, Stine N, JAMA: the Journal of the American Medical Association . 2006,第16期

机译：食品和药物管理局药品咨询委员会会议上的财务利益冲突披露和投票方式。
2. Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database [J] . Florek A.G., Nardone B., Thareja S., British Journal of Dermatology . 2017,第5期

机译：Malignancies和Ustekinumab：美国食品和药物管理局的分析不良事件报告制度和欧盟药物调节机构药物检修数据库
3. Drug Safety, the U.S. Food and Drug Administration and Statistical Data Mining [J] . MICHAEL OCONNELL Scientific computing . 2006,第7期

机译：药品安全，美国食品药品监督管理局和统计数据挖掘
4. Analytic Scheme to Organize Large Archived Data into Hierarchical Affinity: A Case of Adverse Outcome Reports of the U.S. Food and Drug Administration Database [C] . Inki Kim, Gul E. Okudan Kremer Annual Conference and Expo of the Institute of Industrial Engineers . 2014

机译：分析方案将大型存档数据组织成分层亲和力：美国食品和药物管理局数据库的不利结果报告的情况
5. The Food and Drug Administration's new drug approvals and market withdrawals for safety under the Prescription Drug User Fee Act and the Food and Drug Modernization Act. [D] . Dziurzynski, Bogdan. 2005

机译：食品和药物管理局根据《处方药使用者费用法》和《食品和药物现代化法》为安全起见批准了新药，并撤出了市场。
6. Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration [O] . Helen W. Sullivan, Kathryn J. Aikin, Eunice Chung-Davies, -1

机译：2001年至2014年的处方药促销：来自美国食品药品监督管理局的数据
7. Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration. [O] . Helen W Sullivan, Kathryn J Aikin, Eunice Chung-Davies, 2016

机译：2001 - 2014年处方药促销：美国食品和药物管理局的数据。

Communicating Data Visually: Data Presentation Formats at U.S. Food and Drug Administration Drug Advisory Committee Meetings.

摘要

著录项

相似文献

相关主题

期刊订阅